about
Rift Valley fever virus NSs protein functions and the similarity to other bunyavirus NSs proteinsTemperature-sensitive mutations for live-attenuated Rift Valley fever vaccines: implications from other RNA virusesNovel approaches to develop Rift Valley fever vaccinesRapid Accumulation of Virulent Rift Valley Fever Virus in Mice from an Attenuated Virus Carrying a Single Nucleotide Substitution in the M RNACharacterization of Rift Valley fever virus MP-12 strain encoding NSs of Punta Toro virus or sandfly fever Sicilian virusRift Valley fever virus NSs protein promotes post-transcriptional downregulation of protein kinase PKR and inhibits eIF2alpha phosphorylation.Countermeasure development for Rift Valley fever: deletion, modification or targeting of major virulence factor NSsRift valley fever virus nonstructural protein NSs promotes viral RNA replication and transcription in a minigenome systemDetection of Ebola viral antigen by enzyme-linked immunosorbent assay using a novel monoclonal antibody to nucleoprotein.Analysis of the humoral immune responses among cynomolgus macaque naturally infected with Reston virus during the 1996 outbreak in the Philippines.Rift Valley Fever Virus MP-12 Vaccine Is Fully Attenuated by a Combination of Partial Attenuations in the S, M, and L Segments.Laboratory diagnostic systems for Ebola and Marburg hemorrhagic fevers developed with recombinant proteins.Analysis of linear B-cell epitopes of the nucleoprotein of ebola virus that distinguish ebola virus subtypes.NSm and 78-kilodalton proteins of Rift Valley fever virus are nonessential for viral replication in cell culture.Antigen capture enzyme-linked immunosorbent assay for specific detection of Reston Ebola virus nucleoproteinMP-12 virus containing the clone 13 deletion in the NSs gene prevents lethal disease when administered after Rift Valley fever virus infection in hamstersNSm protein of Rift Valley fever virus suppresses virus-induced apoptosisRift Valley fever virus strain MP-12 enters mammalian host cells via caveola-mediated endocytosis.Genetic subpopulations of Rift Valley fever virus strains ZH548 and MP-12 and recombinant MP-12 strainsModifying the NSs gene to improve live-attenuated vaccine for Rift Valley fever.Rift Valley fever virus NSs inhibits host transcription independently of the degradation of dsRNA-dependent protein kinase PKR.The L, M, and S Segments of Rift Valley Fever Virus MP-12 Vaccine Independently Contribute to a Temperature-Sensitive Phenotype.Optimized P2A for reporter gene insertion into Nipah virus results in efficient ribosomal skipping and wild-type lethalityN-Glycans on the Rift Valley Fever Virus Envelope Glycoproteins Gn and Gc Redundantly Support Viral Infection via DC-SIGN.Mutational Analysis of the Rift Valley Fever Virus Glycoprotein Precursor Proteins for Gn Protein Expression.Rift Valley fever vaccines: an overview of the safety and efficacy of the live-attenuated MP-12 vaccine candidate.NSs protein of rift valley fever virus promotes posttranslational downregulation of the TFIIH subunit p62.Application of Droplet Digital PCR to Validate Rift Valley Fever Vaccines.Rescue of infectious rift valley fever virus entirely from cDNA, analysis of virus lacking the NSs gene, and expression of a foreign gene.Rift valley fever virus L protein forms a biologically active oligomer.Characterization of Rift Valley fever virus transcriptional terminations.Rift Valley fever virus NSs mRNA is transcribed from an incoming anti-viral-sense S RNA segment.Detection of immunoglobulin G to Crimean-Congo hemorrhagic fever virus in sheep sera by recombinant nucleoprotein-based enzyme-linked immunosorbent and immunofluorescence assays.Histopathology of natural Ebola virus subtype Reston infection in cynomolgus macaques during the Philippine outbreak in 1996.Development of an immunofluorescence method for the detection of antibodies to Ebola virus subtype Reston by the use of recombinant nucleoprotein-expressing HeLa cells.Genome structure of Ebola virus subtype Reston: differences among Ebola subtypes. Brief report.Risk analysis of inter-species reassortment through a Rift Valley fever phlebovirus MP-12 vaccine strain.Genetic stability of Rift Valley fever virus MP-12 vaccine during serial passages in culture cells.Enterocolitis associated with dual infection by Clostridium piliforme and feline panleukopenia virus in three kittens.Distinct virulence of Rift Valley fever phlebovirus strains from different genetic lineages in a mouse model.
P50
Q26745530-879D1A87-2CBA-49EF-A948-AAC1A3F2D202Q26796199-23A389C1-36FE-4CE9-9AC5-88ADA2212230Q27027003-EE94D0F3-A47B-47F6-BAFF-EB707FDD7AF5Q27491320-BD9D2794-71D7-495D-80E5-44D34CF9F2B6Q28486276-DC7A79AB-F183-48EA-867B-D29348A91477Q33406230-089864CD-A525-46CB-ACD7-5C50DCBAC95CQ33705717-5C63C475-3EB7-43B0-88CE-8F433A140AADQ33755025-3ED2856D-9D6F-40D2-96BC-116CB6B3D081Q33973424-A5E8EC31-7D8F-474B-B041-D3306E1F000BQ34443570-57C97193-AF15-4501-87E0-33AED81F07DCQ34475358-EEFC744C-4195-483A-9F04-2A5241F6069DQ34512045-CF188FC5-CAA2-4B1F-B9B2-A080E5006627Q34579231-DB22C8FB-470D-485D-8797-960CF9DCE146Q35024013-730200F7-925A-4164-8C33-5D33F70A296FQ35139960-67034B7C-8D4A-4096-BB9D-23D140A7197EQ35792819-039114CB-F66B-4EC7-BD62-164E6F1A2ACCQ36315241-AE3ADF2E-0EBC-4715-96F7-72B5073AA44FQ36397378-EC9D6F02-0AA2-44FA-9BAC-2B5C99FD5112Q36414512-ED581E2F-47AD-458C-88E4-9FCD55C03B64Q36489477-8D8E5264-DB5F-4D4B-BB51-E4D2DCF6FF4EQ36501737-D85426B1-35BD-4908-AA32-4D2C7FDB828EQ36694012-19CA5C7F-8A6C-485A-BB84-927F9D6F2B9CQ36862277-34D78829-E129-44E4-8075-12D1D8E88757Q36947068-919976F4-FE1C-43BA-A4A0-33196518DCA9Q37049951-6228F817-37DC-46AF-AABE-75468F59E132Q39251803-D18B01C9-3C4E-4FB2-AC4B-E3A874294D2EQ39547955-B7B13AD5-CA12-4B74-A45B-702A40FCC090Q40109994-614825A8-D86E-47BD-861D-EA2B48069BBCQ40311587-786F6817-23D1-457C-8A0C-73CD67DC6BDEQ40377637-F4A1C651-6470-4036-AB2B-FB8390D29A26Q40448667-6381EA1B-298B-4206-9569-C9887C5A194FQ40499504-BBC980BC-5FDF-491E-B27B-1400D915029EQ40566120-5B7CED9A-4ABD-4E1E-ABA2-0A59FCB70E82Q40570165-063161C1-4218-4EAA-9D72-552C6341B60FQ40570736-98E895DC-DD7A-495C-BCBA-ABA39D2DFCDAQ40592935-F4E49E76-C183-4530-84F0-8023DC75F1C9Q41677275-C00726C5-4FB5-4104-A4EA-14AC8825EC6DQ44170263-56B8A973-B90C-4747-B62F-E0E8AE2EF527Q45746184-77F71DDA-0B14-46E3-823D-F180ED884335Q47562012-6B6526D3-BB0B-44C5-9192-EB976DEE3DD5
P50
description
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Tetsuro Ikegami
@ast
Tetsuro Ikegami
@en
Tetsuro Ikegami
@es
Tetsuro Ikegami
@sl
type
label
Tetsuro Ikegami
@ast
Tetsuro Ikegami
@en
Tetsuro Ikegami
@es
Tetsuro Ikegami
@sl
prefLabel
Tetsuro Ikegami
@ast
Tetsuro Ikegami
@en
Tetsuro Ikegami
@es
Tetsuro Ikegami
@sl
P106
P31
P496
0000-0001-8318-2783